India's hair intelligence ecosystem
The future of haircare isn't choosing between a doctor, an algorithm, an article or a product. It's building the system that connects them. HairsnCares runs one continuous stack — assessment, clinical knowledge, ingredient intelligence, drug safety, commerce and longitudinal tracking — so your hair journey stops being a research project you have to manage yourself.
Most hair services solve one piece of the problem — a clinic diagnoses, a shop sells, a blog explains, an app tracks — and leave you to join them up. HairsnCares runs all of those as one chain under a single dermatologist's oversight, so an assessment leads into learning, learning into a routine, a routine into tracking, and tracking into a clinician when that is genuinely the next step. The practical difference is that nothing recommends a purchase before it has told you what your problem probably is, and the platform is willing to say when no product will help. It is not better at any one of these than a specialist. It is the handoffs between them that are the product.
Why the industry is broken
Hair loss is unusual among common medical concerns in three ways at once, and every one of them breaks a different part of the internet. It is slow — nothing meaningful happens for four months, which defeats every feedback loop the web is built on. It is multi-causal — genetics, hormones, iron, thyroid, stress, styling and scalp inflammation frequently coexist in the same head, so single-answer content is usually wrong for the person reading it. And it is cosmetic and medical at the same time, which means it gets sold like shampoo and treated like a disease, by two different industries that never speak.
The result is not a shortage of information. India has plenty. The result is that a person losing hair has to become their own physician, pharmacist, researcher, procurement officer and record keeper — five jobs, unpaid, while anxious. Most people manage two of the five and then quietly give up somewhere in month three.
What follows is not a criticism of any company. Each category below is genuinely good at the thing it was built for. The failure is architectural: nobody owns the handoffs.
Superb at diagnosis, trichoscopy and procedures. But the consultation ends, and the eleven months of daily routine that actually decide the outcome happen entirely without it. Nobody sees you again until you're worse.
Stops after diagnosisInfinite shelf, zero clinical logic. Ranking is driven by margin, ad spend and review volume. Two bottles with identical actives sit at a fourfold price gap and nothing on the page tells you they're the same molecule.
Ranks by marginBuilt for cosmetics discovery, and excellent at it. Hair loss is a medical concern wearing a cosmetic costume, and the taxonomy — by brand, by scent, by finish — simply has no slot for "androgenetic, five years, family history".
Wrong taxonomyFluent, confident, unreviewed, and inconsistent between sessions. It will name a molecule without checking you can obtain it in India, at a strength nobody verified against your history, and phrase it with the same certainty either way.
Confident, unverifiedOften explains the science better than the clinic does — then abandons you at the hardest step. Knowing that a 5% topical works is not knowing which of forty Indian products contains it, at what price, with which vehicle.
No next stepRigorous about molecules, silent about you. It can tell you the mechanism of every active in the pharmacopoeia and still cannot tell you which two of them belong in your routine this month, or which one to stop.
Context freeSix months are usually lost not to the wrong product, but to the gaps between six right ones.
Dr. Amit S. Agarkar · MBBS, MD (Dermatology), FCPS, DDV
The cost of fragmentation
This is the pattern described in consulting rooms almost daily. Not a statistic — a shape. It is worth reading because almost every step in it is a reasonable decision made with incomplete information.
Shedding becomes undeniable. The first response is almost always a hair oil or a switch of shampoo — low cost, low risk, and for genuine pattern hair loss, no mechanism of action against the actual problem.
Search, video, forum, reel. Five confident answers that contradict each other, most produced by someone selling the answer. No way to tell which of them was written by anyone who has examined a scalp.
Biotin, multivitamins, a collagen powder. Occasionally correct — if there is a real deficiency. Usually an expensive way to treat a deficiency you never tested for, while the actual driver continues unopposed.
A dermatologist, finally. A correct diagnosis, a correct prescription, ten focused minutes. Then the visit ends, and the daily execution of the plan goes home alone.
Some treatments cause increased shedding in the first weeks — expected, temporary, and almost never explained in the time available. It reads as proof of failure. The treatment is abandoned roughly two months before it would have started working.
A different product, a different source, no record of what was tried, at what dose, for how long, or why it stopped. Every previous year's information is gone. The loop begins again with less hair.
Miniaturised follicles that could have been held four years earlier are now gone, and the discussion has moved from a topical costing a few hundred rupees a month to a surgical one. This is the real price of fragmentation, and it is paid in follicles.
Read that list again and notice what is missing at every stage: not intelligence, and not effort. What is missing is a system that remembers, that explains why something is happening before it happens, and that is still present in month four when the decision to continue or stop is actually made. That absence is the entire reason HairsnCares exists.
The architecture
Most haircare products are features. HairsnCares is built as a stack, because the value is not in any single layer — it is in the fact that each layer is obliged to hand a structured output to the next one. Select a layer to see what feeds it, what it produces, and what it refuses to do.
Everything begins with what you can actually observe about yourself.
The difference, in one shape
The stack describes how the system is built. The loop describes how it behaves. Eight capabilities, each obliged to hand off to the next: the assessment feeds the recommendation, the recommendation cites the ingredient page, the ingredient page links to the product, the product enters your routine, the routine enters your journal, and the journal decides what happens next. Nothing is a dead end, and nothing has to be re-explained.
Protocols and review standards set by a practising dermatologist.
A structured, dermatology-designed intake — not an open-ended chat.
Pattern, density, scalp condition and history read together.
Ingredients first, then the products that contain them.
Every claim links to a reviewed page you can read yourself.
The routine becomes a cart, with nothing added that wasn't explained.
Photo journal and routine log, because hair changes on a monthly clock.
Continue, adjust, or escalate to clinic — decided on evidence, not mood.
Proprietary frameworks
A framework is only worth naming if it changes what the platform actually does. Each of these corresponds to real logic running inside the stack — you can see its output in your own report. Anything that would require testing we do not perform, or a prediction nobody can honestly make, is deliberately absent from this list.
Most hair loss has more than one cause running at once. This maps your answers onto the drivers that are plausibly contributing, rather than forcing a single label.
Actives interact — some usefully, some wastefully, some badly. This checks every pair in a proposed routine before it reaches you.
The most important thing a haircare platform can do is know when to stop selling. This is the rule set that routes you out of the product pathway.
Hair treatment fails on adherence more often than on pharmacology. This asks, before recommending anything, whether the plan is one you can actually run for six months.
Every claim on the platform carries the strength of evidence behind it, so that "proven" and "plausible" never appear in the same typeface.
Several things a haircare platform could market are missing from this page on purpose, because building them would mean asserting knowledge nobody has.
That last card is the one worth pausing on. Any platform can generate a number — "78% recovery probability", "hair health score 62" — and it will always convert better than honesty does. It is also unknowable. Response to hair treatment depends on the correct diagnosis, how long the loss has been running, how far the follicles have miniaturised, adherence, and individual factors that cannot be read from a questionnaire. A number implies a precision that does not exist, and on a page carrying a doctor's registration, it is not a marketing decision — it is a medical claim. So instead of predicting your outcome, the platform gives you the one thing that is genuinely knowable in advance: the timeline on which each treatment can be fairly judged, which appears further down this page.
Category comparison
This compares categories of platform, not companies. A clinic is superb at what a clinic does; so is a marketplace, and both hold marks below that HairsnCares does not — including the two capabilities at the very top, where our column reads zero. The question here is coverage — how much of one hair journey a single category can carry before handing you back to the open internet.
| Capability | Traditional clinics | Generic ecommerce | Beauty marketplaces | AI chatbots | Hair blogs | HairsnCares |
|---|---|---|---|---|---|---|
| Physical examination | ● | ○ | ○ | ○ | ○ | ○ |
| Confirmed diagnosis | ● | ○ | ○ | ○ | ○ | ○ |
| Provisional assessment | ● | ○ | ○ | ◐ | ○ | ● |
| Dermatologist led | ● | ○ | ○ | ○ | ◐ | ● |
| Clinical education | ◐ | ○ | ○ | ◐ | ● | ● |
| Structured hair assessment | ● | ○ | ○ | ◐ | ○ | ● |
| Ingredient intelligence | ◐ | ○ | ◐ | ◐ | ● | ● |
| Personalised product matching | ● | ○ | ◐ | ◐ | ○ | ● |
| Natural & ayurvedic range | ○ | ● | ● | ○ | ○ | ● |
| Pharma haircare | ● | ◐ | ○ | ○ | ○ | ● |
| Hair cosmetics & styling | ○ | ● | ● | ○ | ○ | ● |
| Treatment appliances | ◐ | ● | ◐ | ○ | ○ | ● |
| Routine builder | ◐ | ○ | ○ | ◐ | ○ | ● |
| Drug safety information | ● | ○ | ○ | ◐ | ◐ | ● |
| Progress tracking | ◐ | ○ | ○ | ○ | ○ | ● |
| Hair journals | ○ | ○ | ○ | ○ | ◐ | ● |
| Comparison articles | ○ | ○ | ○ | ◐ | ● | ● |
| Integrated shopping | ◐ | ● | ● | ○ | ○ | ● |
| Single connected ecosystem | ○ | ○ | ○ | ○ | ○ | ● |
| Clinical decision support | ● | ○ | ○ | ◐ | ○ | ● |
| Lifestyle & nutrition guidance | ◐ | ○ | ○ | ◐ | ● | ● |
| Root-cause focus | ● | ○ | ○ | ◐ | ◐ | ● |
| Premium end-to-end experience | ◐ | ◐ | ● | ○ | ○ | ● |
| Coverage of the full journey | 61% | 22% | 24% | 24% | 26% | 91% |
Swipe the table sideways to see all categories →
Read the first three rows together, because the distinction between them is the entire basis of the platform. No online system can examine your scalp or confirm a diagnosis — those require a clinician, a dermatoscope and often a blood test, and any platform implying otherwise is selling something. What a structured assessment genuinely can do is form a provisional assessment: a documented working impression of what your presentation most resembles, with its drivers ranked and its uncertainties printed. That is exactly what a clinician forms before examination confirms or overturns it — and it is the output that makes the remaining twenty rows possible. It is also why the ninth layer of the stack exists: the system is built to recognise the point at which a provisional assessment must become a confirmed one, and to hand you to a human being without first putting a product in your basket. Coverage percentages are the share of the twenty-three capabilities listed, scoring a full mark as one and a partial as one half; you are welcome to count the marks yourself.
Pillar one · Dermatology
The platform's spine is clinical practice, not a content calendar. Protocols are written first; the catalogue is arranged to serve them, and not the reverse. That order of operations is the single most consequential decision in the whole system.
Pillar two · Intelligence
The assessment isn't a chat window. It's a fixed clinical intake, designed by a dermatologist, that turns scattered symptoms into a structured report — and returns the same reasoning for the same inputs, every time, which a conversational model cannot promise.
Pillar three · Recommendation
Most engines rank what sells. This one ranks what fits — and shows its reasoning, so you are equipped to disagree with it. A recommendation you cannot interrogate is just an advertisement with better manners.
Pillar four · Commerce
The catalogue depth you would expect from a marketplace, organised the way a dermatologist would arrange a pharmacy: by what a thing does, not by who paid for the end cap.
Product intelligence
The phrase "recommended for you" is the least informative sentence in ecommerce. Every product surfaced by the platform carries a fixed set of fields instead — the same fields, every time, so that two products can be compared on something other than their photography.
Cost per month is the field the industry avoids. Two products with identical actives can differ fourfold once you normalise for concentration and quantity, and nothing on a conventional product page makes that visible. Normalising it is not generosity — it is the natural consequence of recommending a molecule rather than a bottle.
"If it fails" is the field nobody writes. Every protocol has a decision point, and the honest thing is to publish it before you buy, not after. Knowing at the outset that month six is the review date, and knowing what happens then, is what stops a person from quietly abandoning a working treatment in week nine.
"Avoid with" costs sales, on purpose. Flagging that two items in a basket duplicate the same mechanism removes one of them from that basket. A system that only ever adds is a system optimised for the wrong outcome, and over a six-month course, the trust is worth more than the second bottle.
Together these fields have a single effect: they make the recommendation falsifiable. You can check the ingredient page, check the evidence grade, check the price against an equivalent, and conclude that the platform is wrong. That is the point. A recommendation that cannot be checked is not intelligence — it is just confidence with a bigger budget.
Product Science™
Before choosing a shampoo, serum, supplement or treatment, you should be able to see the chemistry, the biology, the evidence and the dermatology behind the formulation. Product Science is the reference layer that makes that possible — a scientific library rather than a catalogue. Knowledge first. Products second.
Below is the explorer in miniature. Choose an active on the left and the diagram shows where in the follicle it actually acts — the single fact that separates a treatment from a cosmetic, and the one almost no product page tells you.
Educational reference only. Concentrations, suitability, combinations and duration are individual decisions — prescription items in particular require a dermatologist. Nothing here is a recommendation for any specific person.
Every category has a ceiling — a thing it can genuinely do and a thing it cannot. Stating both is the whole purpose of the library.
Excellent for the fibre and for pre-wash protection. Evidence for reversing follicular loss is thin.
BCleansing plus a delivery vehicle for medicated actives. Contact time matters more than lather.
AReliably reduce breakage and friction. That is fibre preservation, not follicle treatment.
A–CThe widest evidence spread of any category. The grade depends entirely on the active inside.
BStrong where a deficiency is documented. Close to inert where none exists.
AThe best-studied options, and the slowest to show change. Both facts belong together.
AHighest evidence, real contraindications, dermatologist-directed. Never self-prescribed.
—Immediate cosmetic camouflage, honestly labelled as such. No biological effect whatsoever.
—Appearance and hold. Matter mostly through the mechanical stress they add or remove.
BLight-based devices have reasonable data and demand sustained use. Commitment before purchase.
BDeep conditioning for damaged fibre. Judged on protein–moisture balance, not fragrance.
BControl inflammation and scale — often the step that makes everything else start working.
—Colour, texture and finish. Presented as cosmetic, never dressed up as treatment.
CSmoothing and bonding chemistry, with the trade-off in fibre integrity stated up front.
Nine dimensions assessed for every product in the library, so two bottles can be compared on something other than their photography.
The mechanism, stated in one plain sentence, and the layer of the follicle it acts on.
Grade A to D, with what the grade rests on — and the verbs that grade permits.
Concentration, vehicle and pH, because the same active behaves differently in a different base.
What it duplicates, what it destabilises, and what genuinely belongs alongside it.
Pregnancy and breastfeeding status, adverse effects, interactions, and who should not use it.
The concerns and hair types it fits, and the presentations it will not help at all.
When change becomes assessable, and the review date at which to decide.
Same active, other products — including the cheaper equivalents, shown side by side.
A signed clinical comment, including the reasons not to use it. Written by a person, not generated.
You may notice a tenth dimension missing. Several platforms publish an "AI confidence score" next to a product, and it converts extremely well — a number implies a machine checked something. In practice it is a weighting of the same evidence grade already shown in dimension two, wearing a decimal point to look precise. The matrix shows you the grade and the reasoning instead, and lets you do the weighting yourself.
The complete ecosystem
Twenty modules, one dependency chain. The test of an ecosystem is not how many modules it has — it is whether any of them can be removed without the others noticing.
The structured assessment. Feeds every other module downstream.
Presentation, drivers, uncertainties and a starting routine.
Every active, with mechanism, evidence grade and timeline.
Cautions, pregnancy categories and known interactions.
Morning and night sequence, frequency, duration, conflicts.
The biology behind every recommendation, written to be read.
Treatment against treatment, on evidence and on cost.
Because texture changes what a routine should look like.
Topicals and oral agents, with strength and vehicle stated.
Traditional formulations, same labelling standard as pharma.
For documented need, flagged when there is no reason to suspect one.
Cleansing and medicated, indexed by active rather than fragrance.
Fibre care, chosen against texture and processing history.
What they can do for the fibre, and what they cannot do for the follicle.
Camouflage and styling, presented as cosmetic, never as treatment.
Scalp and light devices, with the commitment stated before the price.
A whole protocol as one purchase, so nothing goes missing.
Monthly photographs under fixed conditions, plus adherence.
The timeline view that makes slow change visible at all.
A dermatologist, with your report and journal already in hand.
The dependency chain is the product. A hair journal without an assessment is a photo album. An ingredient library without a routine builder is an encyclopaedia. A store without either is a shelf. What makes this an ecosystem rather than a feature list is that the output of each module is the required input of the next — and that when you arrive at a consultation in the eighth layer, the dermatologist opens six months of structured history instead of asking you to remember it.
Trust architecture
Anyone can print "dermatologist approved" on a page. What follows is the actual governance — who writes, who reviews, on what evidence, on what cycle, and what happens when the evidence changes. If it isn't inspectable, it isn't trust; it's decoration.
Clinical content is drafted against a written protocol, not commissioned from a brief. The protocol exists before the article, and the article cannot exceed it.
Every clinical page is reviewed by a named dermatologist with stated qualifications and a visible review date. Anonymity is where accountability goes to hide.
Each claim carries a grade from A to D. A grade D active can still be listed — it simply cannot be described in the language reserved for grade A.
Protocols are written before the catalogue is consulted. Margin has no input into which ingredient class a protocol recommends, and the two are edited separately.
Pages are re-reviewed on a schedule, and out of cycle whenever a regulatory change, safety communication or significant trial affects a recommendation.
The platform publishes what it cannot do, in the same typeface as what it can. Every page that could be mistaken for diagnosis says plainly that it is not.
Applied to every active in the ingredient library, and printed on the recommendation itself.
The grades matter less than the rule attached to them. An active's grade determines the verbs the platform is allowed to use about it. A traditional oil with grade D evidence can be sold, described accurately and enjoyed — it simply cannot borrow the word "proven" from a molecule that earned it in a controlled trial. Most misleading haircare copy in India is not a false statement; it is a grade D ingredient wearing grade A language.
The biology underneath
Almost every bad decision in haircare comes from one misunderstanding: hair does not respond on a human attention span. Each follicle runs an independent cycle, and a treatment cannot show a result faster than that cycle allows — no matter what it costs.
Lasts roughly two to seven years, and determines how long your hair can ever get. Around 85–90% of scalp follicles are here at any moment. Treatments that work do so by protecting or extending this phase — which is why nothing visible happens quickly.
A brief regression of two to three weeks, affecting about 1% of follicles at a time. Short, silent, and not something any product meaningfully influences.
Roughly three months of rest before the hair is released and a new one begins. Losing 50–100 hairs a day is normal traffic through this phase, not loss. A stressor, illness, delivery or crash diet pushes many follicles into telogen at once — and the shedding appears two to three months later, which is why the cause is almost always missed.
Two practical consequences follow, and they explain most of what the platform does. First: the shedding you notice today usually began two to three months ago. Asking what changed last week is the wrong question; asking what happened in the previous quarter — an illness, a fever, a delivery, a surgery, a diet, a bereavement — is the right one, and the assessment is built to ask it.
Second: a treatment cannot outrun the cycle. Because a follicle must complete telogen before it can re-enter anagen, no topical or oral agent can show meaningful density change in weeks. Some treatments even increase shedding at first, as resting hairs are released to make way for new growth — a sign of the mechanism engaging, routinely mistaken for harm. This is precisely where people quit, and it is the reason the platform prints the timeline before it prints the price.
Honest timelines
This is the chart that replaces a fabricated regrowth score. Not what you will get — nobody honestly knows that — but when each intervention can fairly be assessed, so you neither quit early nor persist for years with something inert.
Read the chart top to bottom and the logic of the whole platform appears in one image. The interventions that act fastest change the least — camouflage and conditioner work in days because they act on the fibre you already have. The interventions that change the most act slowest, because they act on the follicle and must wait for the cycle. A market that sells on before-and-afters will always over-represent the top of this chart. A system built for outcomes has to be honest about the bottom of it.
Hair Science University™
Every hair concern, every treatment, every ingredient and every condition — explained by dermatologists, using evidence instead of myths. Not a blog and not a feed: a structured curriculum, arranged the way the subject is actually taught, so you can start at whatever depth you need and go further when you want to.
Four levels. Five faculties. Twenty-two domains. Choose a level to see what it covers.
—
Every article in the library belongs to exactly one faculty, and every faculty links back into the assessment, the ingredient library and the store — so learning something never leaves you without a next step.
The structures themselves. Read this faculty and most haircare marketing becomes transparent.
What goes wrong, how each presentation differs, and which ones need a clinic today rather than a product.
What each option does, what it costs in time, and the honest ceiling of every intervention.
The chemistry layer, shared with Product Science — what is in the bottle and why it is in there.
Everything that reaches the follicle through the bloodstream rather than through a bottle.
Where the evidence grades come from. Understanding these five study types is the difference between reading a headline and reading a result.
Pools many trials to find the true size of an effect. Strongest single source, and only as good as the trials inside it.
Allocation by chance, ideally blinded. The only design that reliably separates a treatment from time passing.
Follow real groups over years. Excellent for safety signals, vulnerable to confounding on effectiveness.
A handful of patients described in detail. Generates hypotheses; settles nothing on its own.
Cells and cultured follicles. Explains mechanism beautifully, and frequently fails to survive contact with a human scalp.
That last card explains most of the haircare internet. An ingredient performs impressively on cultured follicles, a press release follows, and the finding arrives on a label as though it had been proven on people. It is not dishonest so much as untranslated — and knowing the difference between a laboratory result and a clinical one is the single most useful thing this library can teach you.
Why this matters
Eight decisions · Six sources · No record
One system · One record · One timeline
What's actually behind the platform
Clinical content is attributed to a practising dermatologist by name and qualification, with a visible review date — not to an anonymous "expert team".
The hair test and its report cost nothing and require no purchase. If the honest answer is "see a doctor", that is what the report says, and no products appear.
Every product is indexed by its actives, and every active has a reference page with an evidence grade. You can always check what you are being sold, and why.
Pregnancy, breastfeeding and interaction cautions appear on the ingredient page and again before checkout — not buried in a leaflet inside the box.
Every recommendation states when change becomes assessable and when to conclude something is not working, before you are asked to pay for it.
Availability, generic equivalents, prescription status, pricing, climate, water hardness and the hair types actually represented here — not translated from a US catalogue.
HairsnCares provides health information and products. It is not a substitute for examination, diagnosis or prescription by a qualified medical practitioner, and no content on this page constitutes a diagnosis or a promise of result. If you have sudden or severe hair loss, patchy loss, scalp pain, scarring, bleeding or associated systemic symptoms, consult a dermatologist directly rather than starting any product.
Questions people actually ask
HairsnCares is a dermatologist-led hair intelligence platform. It combines a structured hair assessment, dermatologist-reviewed education, ingredient intelligence, drug safety information, a routine builder, a curated haircare store and a longitudinal hair journal in one place, so you don't have to assemble your hair journey from separate clinics, blogs, chatbots and marketplaces.
Both functions sit inside one system. The clinical layer supplies dermatologist-reviewed protocols and education; the commerce layer lets you act on that guidance by obtaining the products a routine calls for. The assessment connects the two, and the hair journal keeps a record over time.
Content is written and reviewed under the direction of Dr. Amit S. Agarkar, MBBS, MD (Dermatology), FCPS, DDV — a dermatologist, trichologist and hair transplant surgeon practising in Mumbai. Clinical pages carry the date they were last reviewed.
Pharma haircare, natural and ayurvedic formulations, nutritional supplements, hair cosmetics and styling, hair fibres, scalp and hair appliances, and combined clinical kits — grouped by concern and by active ingredient rather than only by brand.
The assessment, report, ingredient library, learn articles and hair journal cost nothing. You pay only for products you choose to buy, and for a consultation if you book one.
Yes. Delivery timelines and availability for specific pharma items are shown on each product page and confirmed at checkout.
No. It is a structured intake and decision-support tool. It organises your history, pattern, scalp signs and goals into a report and suggests a starting routine. It does not diagnose. Anything that needs physical examination, trichoscopy, blood investigation or prescription medicine needs a dermatologist.
A general chatbot answers whatever it is asked, from open web text, with no clinical review step and no obligation to be consistent between sessions. The HairsnCares assessment runs a fixed dermatology-designed question set, maps answers to reviewed protocols, and returns the same reasoning for the same inputs, tied to ingredients and products actually available in India.
The presentation your answers most resemble, the factors that appear to be contributing, what is worth ruling out with a doctor, an ingredient-level starting routine with timelines, safety cautions relevant to your answers, and an explicit statement of where confidence is low and why.
No, and any platform that offers you a regrowth percentage is guessing. Response to hair treatment depends on the correct diagnosis, how long the loss has been running, how far the follicles have miniaturised, adherence and individual factors that cannot be read from a questionnaire. What HairsnCares provides instead is the evidence-based timeline for each active — when a change would typically become visible, and when to conclude that something is not working.
For most topical and oral hair treatments, meaningful assessment is not possible before about four months, and six months is a fairer decision point. Early increased shedding in the first weeks of some treatments is expected rather than a failure. Judging at week three is the single most common reason people abandon treatments that were about to work.
You photograph the same three views under the same lighting on day zero and then monthly, and log adherence to your routine. Because hair changes on a scale of months, a side-by-side timeline is the only reliable way to see change — memory and mirrors are not.
Every product is indexed by its active ingredients, and every ingredient has a reference page covering mechanism, evidence level, realistic timeline, typical concentration, and known cautions and interactions. You can search by molecule rather than by marketing claim, and compare two products by what is actually inside them.
Ingredient and drug pages carry pregnancy and breastfeeding categories, common adverse effects, and known interactions, and these are surfaced again before checkout rather than buried in a leaflet. This is reference information, not a personal safety clearance — confirm against your own medication list with your treating doctor or pharmacist.
Recommendations are generated at the level of the active ingredient first, and where several products contain the same active at the same strength, the alternatives are shown together including cheaper ones. If the honest answer is an inexpensive generic, that is what appears.
No. The assessment and the resulting report are free to take and free to read, with no purchase required and no results withheld behind a payment. Products are optional, and the report is yours to take to any dermatologist you choose.
The platform is explicit about its limits. Where a concern points to in-clinic treatment — advanced pattern hair loss, scarring alopecia, suspected autoimmune causes or transplant evaluation — the report says so and directs you to a consultation instead of selling you a product.
Sudden patchy hair loss, hair loss with scalp pain, scarring, pustules, bleeding or scaling plaques, hair loss in children, and hair loss with systemic symptoms all need direct medical assessment first. The assessment is designed to flag these and route you out of the product pathway rather than into it.
Yes. Female pattern hair loss, postpartum shedding, hair loss around menopause and traction alopecia from styling are handled as distinct presentations with their own protocols, because the treatment logic and the safety cautions genuinely differ.
Assessment answers and journal photographs are personal health information and are handled under the platform privacy policy. They are used to generate and improve your own report and routine, and are not sold. Full detail, including retention and deletion, is set out in the privacy policy.
Clinical pages carry a visible last-reviewed date and are re-checked on a scheduled cycle, and out of cycle whenever a regulatory change, safety communication or significant new trial affects the recommendation.
Product availability, brand and generic equivalents, prescription status, pricing, climate and water hardness effects, common dietary deficiency patterns and the hair types most represented in India — none of which translate cleanly from a US or European catalogue.
The assessment answers more than a page of questions can — and if the honest answer is “see a dermatologist”, it says so and shows you no products.
Start with the assessment. It costs nothing, takes about eight minutes, and ends with a report you can act on — or take to any dermatologist you like.
Each source below supports something specific written above, and each opens in a new tab. None of them endorses this platform.
Your cart is empty